Holen Sie sich die Stockscreener-App
27.40
1.69%
-0.47
Handel nachbörslich:
27.40
Schlusskurs vom Vortag:
$27.87
Offen:
$27.87
24-Stunden-Volumen:
67,392
Relative Volume:
0.66
Marktkapitalisierung:
$314.74M
Einnahmen:
$3.48M
Nettoeinkommen (Verlust:
$-259.96M
KGV:
-0.7383
EPS:
-37.1111
Netto-Cashflow:
$-30.37M
1W Leistung:
-0.18%
1M Leistung:
+1.33%
6M Leistung:
+97.98%
1J Leistung:
+149.32%
1-Tages-Spanne:
$26.91
$28.59
1-Wochen-Bereich:
$26.91
$29.99
52-Wochen-Spanne:
$5.90
$29.99
Surrozen Inc Stock (SRZN) Company Profile
Firmenname
Surrozen Inc
Sektor
Branche
Telefon
650-475-2820
Adresse
171 OYSTER POINT BLVD, SOUTH SAN FRANCISCO
Compare SRZN vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SRZN
Surrozen Inc
|
27.40 | 320.13M | 3.48M | -259.96M | -30.37M | -37.11 |
VRTX
Vertex Pharmaceuticals Inc
|
434.30 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
763.04 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
748.25 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.34 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.81 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Surrozen Inc Stock (SRZN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-19 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-01-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-01-03 | Hochstufung | Guggenheim | Neutral → Buy |
| 2021-10-11 | Eingeleitet | BofA Securities | Buy |
| 2021-09-15 | Eingeleitet | Guggenheim | Buy |
| 2021-09-07 | Eingeleitet | Stifel | Buy |
Alle ansehen
Surrozen Inc Aktie (SRZN) Neueste Nachrichten
SRZN PE Ratio & Valuation, Is SRZN Overvalued - Intellectia AI
Responsive Playbooks and the SRZN Inflection - Stock Traders Daily
SRZN Stock Price, Quote & Chart | SURROZEN INC (NASDAQ:SRZN) - ChartMill
Surrozen (SRZN) EVP Li Yang donates 1,666 common shares in Form 4 - Stock Titan
[ARS] Surrozen, Inc./DE SEC Filing - Stock Titan
Executive pay and board elections headline Surrozen (NASDAQ: SRZN) 2026 meeting - Stock Titan
[EFFECT] Surrozen, Inc./DE SEC Filing - Stock Titan
Surrozen (NASDAQ: SRZN) sets $50M ATM shelf with TD Cowen - Stock Titan
Short Squeeze: Should value investors consider Surrozen Inc Equity Warrant2026 Chart Watch & Long-Term Growth Stock Strategies - baoquankhu1.vn
Surrozen (NASDAQ:SRZN) Upgraded at Wall Street Zen - Defense World
What is Lifesci Capital’s Forecast for Surrozen Q1 Earnings? - Defense World
Breakout Zone: Is Surrozen Inc Equity Warrant attractive for institutional investorsRate Cut & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Wednesday’s insider activity: Major buys at Surrozen and MGM Resorts - Investing.com
Guggenheim Keeps Their Buy Rating on Surrozen (SRZN) - The Globe and Mail
What is Lifesci Capital's Forecast for Surrozen Q1 Earnings? - MarketBeat
What is HC Wainwright's Forecast for Surrozen Q1 Earnings? - MarketBeat
Guidance Update: Can Surrozen Inc Equity Warrant lead its sector in growth2026 Buyback Activity & AI Enhanced Trade Execution Alerts - baoquankhu1.vn
HC Wainwright Forecasts Surrozen FY2030 Earnings - Defense World
Insider Buying: Surrozen (NASDAQ:SRZN) Major Shareholder Buys $2,633,386.02 in Stock - MarketBeat
Surrozen (NASDAQ:SRZN) Major Shareholder Buys $379,052.70 in Stock - MarketBeat
TCG Crossover funds boost Surrozen (SRZN) stake with open-market buys - stocktitan.net
TCG crossover funds buys Surrozen (SRZN) shares worth $3m By Investing.com - Investing.com South Africa
TCG crossover funds buys Surrozen (SRZN) shares worth $3m - Investing.com
Earnings Risk: Is Surrozen Inc a cyclical or defensive stock2026 Sentiment & Proven Capital Preservation Methods - baoquankhu1.vn
Cantor Fitzgerald Sticks to Their Buy Rating for Surrozen (SRZN) - The Globe and Mail
HC Wainwright Weighs in on Surrozen FY2030 Earnings - MarketBeat
Fed Meeting: Is Surrozen Inc Equity Warrant forming a bullish divergence2026 Price Momentum & Low Drawdown Trading Strategies - baoquankhu1.vn
SRZNW SEC FilingsSurrozen Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Analysts Are Bullish on Top Healthcare Stocks: CSL (CMXHF), Surrozen (SRZN) - The Globe and Mail
Guggenheim reiterates Surrozen stock rating on pipeline progress By Investing.com - Investing.com Canada
Guggenheim reiterates Surrozen stock rating on pipeline progress - Investing.com UK
Cantor Fitzgerald Reaffirms Overweight Rating for Surrozen (NASDAQ:SRZN) - MarketBeat
Cantor Fitzgerald reiterates Overweight on Surrozen stock at $40 By Investing.com - Investing.com South Africa
Cantor Fitzgerald reiterates Overweight on Surrozen stock at $40 - Investing.com UK
Surrozen's (SRZN) Buy Rating Reaffirmed at HC Wainwright - marketbeat.com
SRZN: HC Wainwright & Co. Raises Price Target to $36, Reiterates Buy Rating | SRZN Stock News - gurufocus.com
Surrozen Reports 2025 Financial Results, Advances Retinal Disease Therapies, and Announces $5M Milestone from Boehringer Ingelheim - Minichart
Surrozen, Inc. 2025 Annual Report: Advancing Wnt Pathway Modulation for Ophthalmic Disease Treatment 50 - Minichart
Surrozen Reports Q4 and Full Year 2025 Financial Results, Provides Business UpdateSouth San Francisco Today - National Today
Surrozen (NASDAQ: SRZN) files $200M shelf to sell stock, debt, warrants - Stock Titan
Surrozen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - Investing News Network
Surrozen (NASDAQ:SRZN) Releases Earnings Results, Misses Expectations By $6.30 EPS - MarketBeat
Surrozen 10-K: Revenue $3.48M, EPS $(32.37) — steep net loss from financing charges - TradingView
[10-K] Surrozen, Inc./DE Files Annual Report - Stock Titan
Surrozen, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
SRZN: Cash rose to $89M, net loss widened to $242M, IND for SZN-8141 expected H2 2026 - TradingView
Surrozen (NASDAQ: SRZN) posts 2025 loss but boosts cash for eye programs - Stock Titan
BRIEF-Surrozen FY EPS USD -32.37 - TradingView
$5M milestone moves Surrozen toward an eye drug IND filing - Stock Titan
Surrozen (SRZN) to Release Quarterly Earnings on Monday - Defense World
Understanding the Setup: (SRZN) and Scalable Risk - Stock Traders Daily
Finanzdaten der Surrozen Inc-Aktie (SRZN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Surrozen Inc-Aktie (SRZN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| TCG Crossover GP II, LLC | 10% Owner |
Mar 23 '26 |
Buy |
24.90 |
15,223 |
379,051 |
683,225 |
| TCG Crossover GP II, LLC | 10% Owner |
Mar 13 '26 |
Buy |
24.88 |
35,433 |
881,463 |
675,018 |
| TCG Crossover GP II, LLC | 10% Owner |
Mar 12 '26 |
Buy |
24.99 |
12,374 |
309,166 |
657,301 |
| TCG Crossover GP II, LLC | 10% Owner |
Mar 16 '26 |
Buy |
24.99 |
1,190 |
29,733 |
675,613 |
| TCG Crossover GP II, LLC | 10% Owner |
Feb 11 '26 |
Buy |
23.57 |
17,763 |
418,763 |
650,567 |
| TCG Crossover GP II, LLC | 10% Owner |
Feb 12 '26 |
Buy |
23.86 |
1,093 |
26,082 |
651,114 |
| TCG Crossover GP II, LLC | 10% Owner |
Feb 03 '26 |
Buy |
21.94 |
4,355 |
95,549 |
641,685 |
| TCG Crossover GP II, LLC | 10% Owner |
Jan 30 '26 |
Buy |
21.39 |
4,271 |
91,357 |
639,141 |
| TCG Crossover GP II, LLC | 10% Owner |
Feb 02 '26 |
Buy |
21.38 |
731 |
15,629 |
639,507 |
| COLUMN GROUP III GP, LP | 10% Owner |
Jan 20 '26 |
Buy |
19.60 |
18,052 |
353,817 |
1,016,658 |
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):